Delivery Order SPE2DB24D2101-SPE2DB25FKNUM
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $17,135.28 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price, competitively awarded contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is unencumbered by...
- The Defense Logistics Agency awarded a delivery order valued at $2,855.88 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a biologic medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, and represents performance from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a $11,893.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Orencia 125 mg/ml syringes. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.94 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials. This competitively awarded, firm fixed-price contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. No set-aside designation was applied to this award, demonstrating the contractor's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Orencia 250 mg vials, a biologic immunosuppressant medication used primarily for rheumatoid arthritis treatment. This firm fixed price delivery order, valued at $6,942.46, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by August 26, 2025. The award was placed with AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $8,567.64 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $20,773.97 on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Orencia 125 mg/ml syringes valued at $14,495.04. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $10,782.12 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $17,488.86 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside delivery order is scheduled for ultimate completion on August 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNUMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,362.12 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials. This firm fixed price contract, issued on August 22, 2025, represents a non-set-aside award with an ultimate completion date of August 25, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Orencia is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions, supporting the Defense Health Agency's medical supply requirements for military personnel and beneficiaries. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the federal government, AmerisourceBergen maintains a comprehensive portfolio supplying medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling flexible fulfillment of Defense Department medical supply needs across multiple therapeutic domains and geographic locations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/22/25 |